Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Peruzzi

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Plos One|September 1, 2021
Effectiveness of anti-vascular endothelial growth factors in neovascular age-related macular degeneration and variables associated with visual acuity outcomes: Results from the EAGLE studyGiovanni Staurenghi, Francesco Bandello, Francesco Viola, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 21, 2023
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancerElena Peruzzi, Lorenzo Gerratana, Marcella Montico, et al.
JAMA Network Open|December 6, 2024
Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer: A Secondary Analysis of the PREPARE Randomized Clinical TrialRossana Roncato, Alessia Bignucolo, Elena Peruzzi, et al.
Oncology Research|September 2, 2024
The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approachesRossana Roncato, Jerry Polesel, Federica Tosi, et al.
Frontiers in Pharmacology|August 9, 2022
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast CancerRossana Roncato, Lorenzo Gerratana, Lorenza Palmero, et al.
ESC Heart Failure|December 2, 2023
Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEFMassimo Iacoviello, Gabriele Di Gesaro, Filippo Maria Sarullo, et al.
Journal of Clinical Medicine|January 21, 2023
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study)Andrea Di Lenarda, Gabriele Di Gesaro, Filippo Maria Sarullo, et al.
Oncogene|September 25, 2025
Integration of germline pharmacogenomic burden to predict fluoropyrimidine-related toxicity - A secondary analysis of the PREPARE trialElena De Mattia, Yoomi Park, Elena Peruzzi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 9, 2023
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposureRossana Roncato, Elena Peruzzi, Lorenzo Gerratana, et al.
Frontiers in Cardiovascular Medicine|May 27, 2024
Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fractionFilippo Maria Sarullo, Cinzia Nugara, Silvia Sarullo, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Plos One|September 1, 2021
Effectiveness of anti-vascular endothelial growth factors in neovascular age-related macular degeneration and variables associated with visual acuity outcomes: Results from the EAGLE studyGiovanni Staurenghi, Francesco Bandello, Francesco Viola, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 21, 2023
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancerElena Peruzzi, Lorenzo Gerratana, Marcella Montico, et al.
JAMA Network Open|December 6, 2024
Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer: A Secondary Analysis of the PREPARE Randomized Clinical TrialRossana Roncato, Alessia Bignucolo, Elena Peruzzi, et al.
Oncology Research|September 2, 2024
The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approachesRossana Roncato, Jerry Polesel, Federica Tosi, et al.
Frontiers in Pharmacology|August 9, 2022
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast CancerRossana Roncato, Lorenzo Gerratana, Lorenza Palmero, et al.
ESC Heart Failure|December 2, 2023
Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEFMassimo Iacoviello, Gabriele Di Gesaro, Filippo Maria Sarullo, et al.
Journal of Clinical Medicine|January 21, 2023
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study)Andrea Di Lenarda, Gabriele Di Gesaro, Filippo Maria Sarullo, et al.
Oncogene|September 25, 2025
Integration of germline pharmacogenomic burden to predict fluoropyrimidine-related toxicity - A secondary analysis of the PREPARE trialElena De Mattia, Yoomi Park, Elena Peruzzi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 9, 2023
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposureRossana Roncato, Elena Peruzzi, Lorenzo Gerratana, et al.
Frontiers in Cardiovascular Medicine|May 27, 2024
Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fractionFilippo Maria Sarullo, Cinzia Nugara, Silvia Sarullo, et al.
Pageof 3